Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia

Bone Marrow Transplantation

Volumn 18, Issue 5, 1996, Pages 879-884

  Boque C ^a,c   Petit, J ^a   Sarra J ^a   Cancelas, J A ^a   Munoz J ^a   Espanol J I ^a   De La Banda, E ^a   Aventin, A ^b   Berlanga, J ^a   Ferra C ^a   Amill, B ^a   Torrico, C ^a   Azqueta, C ^a   Llucia M ^a   Garcia J ^a   Granena A ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c NONE   (Spain)

Author keywords

Chronic myeloid leukemia; G CSF; Intensive chemotherapy; Peripheral stem cell mobilization

Indexed keywords

CYTARABINE; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN;

ADULT; APHERESIS; ARTICLE; AUTOGRAFT; BACTEREMIA; CANCER MORTALITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOGENETICS; FEMALE; HUMAN; INFECTIOUS COMPLICATION; LEUKAPHERESIS; LIVER TOXICITY; LUNG ASPERGILLOSIS; MALE; MONONUCLEAR CELL; MUCOSA INFLAMMATION; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RASH; VASCULITIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL SEPARATION; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED;

EID: 10544250653     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Goldman JM. Management of chronic myeloid leukaemia. Blood Rev 1994; 8: 21-29.
2. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC. Phenotypic heterogeneity in primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 1992; 80: 2522-2530.
3. Dunbar CE, Stewart FM. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood 1992; 79: 1107-1110.
4. O'Brien SG, Goldman JM. Current approaches to hematopoietic stem-cell purging in chronic meyloid leukemia. J Clin Oncol 1995; 13: 541-546.
5. McGlave PB, De Fabritiis P, Deisseroth A et al. Autologous transplants for chronic myeloid leukemia: results from eight transplant groups. Lancet 1994; 343: 1486-1488.
6. Reiffers J, Goldman JM, Meloni JM et al. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-410.
7. Diesseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3976.
8. Simonsson B, Öberg G, Killandar A et al. Intensive treatment in order to minimize the Ph' positive clone in chronic myelogenic leukemia. Stem Cells 1993; 11 (Suppl. 3): 73-76.
9. Carella AM, Podesta M, Frasoni F et al. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myeloid leukemia. Bone Marrow Transplant 1993; 12: 267-271.
10. Carella AM, Frasoni F, Pollicardo N et al. Ph-negative blood progenitor cell (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea. Bone Marrow Transplant 1994; 14: 34-37.
11. Kantarjian HM, Talpaz M, Hester J et al. Collection of peripheral-blood diploid cells from chronic myeloid leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. J Clin Oncol 1995; 13: 553-559.
12. Cancelas JA, Querol S, Canals C et al. CD34+ cell positive selection from mobilized peripheral blood by an indirect immunomagnetic method: effect of the type of mobilization and assessment of tumor depletion ability. J Hematother 1995; 4: 531-538.
13. Pike B, Robinson WA. Human bone marrow colony growth in agar gel. J Cell Physiol 1970; 76: 77-81.
14. Gorin NC. Collection, manipulation and freeze thawing of haematopoietic stem cells. Clin Haematol 1986; 15: 19-48.
15. De Fabritiis P, Sandrelli A, Meloni G et al. Prolonged suppression of myeloid progenitors cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant 1990; 6: 247-251.
16. Kantarjian HM, Deisseroth A, Kurzrock R et al. Chronic myelogenous leukemia: a concise update and future directions. Blood 1993; 82: 691-703.
17. Carella AM, Chimirri F, Podestà M et al. High-dose chemoradiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplant 1996; 17: 201-205.